Literature DB >> 23975391

Italian guidelines on thrombolysis indications in ischemic stroke have been revised after IST-3 trial and Cochrane revision: cons.

Giorgio Costantino1, Gian Marco Podda, Mattia Bonzi, Rodolfo Sbrojavacca.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23975391     DOI： 10.1007/s11739-013-0986-y

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  13 in total

1.  rt-PA for ischaemic stroke: what will the next question be?

Authors:  Didier Leys; Charlotte Cordonnier
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

2.  Ischaemic stroke and thrombolysis: ask the onset time, not the age!

Authors:  Silvia Cenciarelli; Tatiana Mazzoli; Stefano Ricci
Journal:  Intern Emerg Med       Date:  2012-11-25       Impact factor: 3.397

3.  rt-PA and stroke: does IST-3 make it all clear or muddy the waters? Answers to the November 2012 Journal Club questions.

Authors:  Ryan P Radecki; Yashwant G Chathampally; Gregory M Press
Journal:  Ann Emerg Med       Date:  2013-04       Impact factor: 5.721

4.  Can we extend thrombolysis indications for acute ischaemic stroke? The IST-3 study.

Authors:  Marta Del Medico; Antonella Bonura
Journal:  Intern Emerg Med       Date:  2013-03-01       Impact factor: 3.397

5.  Evidence based medicine: what it is and what it isn't.

Authors:  D L Sackett; W M Rosenberg; J A Gray; R B Haynes; W S Richardson
Journal:  BMJ       Date:  1996-01-13

6.  Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-Based Medicine Working Group.

Authors:  G H Guyatt; D L Sackett; D J Cook
Journal:  JAMA       Date:  1993-12-01       Impact factor: 56.272

7.  Believing is seeing: stroke thrombolysis remains unproven after the third International Stroke Trial (IST-3).

Authors:  Daniel M Fatovich
Journal:  Emerg Med Australas       Date:  2012-10       Impact factor: 2.151

8.  Eligibility criteria in heart failure randomized controlled trials: a gap between evidence and clinical practice.

Authors:  Giorgio Costantino; Anna Maria Rusconi; Pier Giorgio Duca; Stefano Guzzetti; Ilaria Bossi; Marta Del Medico; Giuseppina Pisano; Mara Bulgheroni; Monica Solbiati; Raffaello Furlan; Nicola Montano
Journal:  Intern Emerg Med       Date:  2008-08-09       Impact factor: 3.397

9.  The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.

Authors:  Peter Sandercock; Joanna M Wardlaw; Richard I Lindley; Martin Dennis; Geoff Cohen; Gordon Murray; Karen Innes; Graham Venables; Anna Czlonkowska; Adam Kobayashi; Stefano Ricci; Veronica Murray; Eivind Berge; Karsten Bruins Slot; Graeme J Hankey; Manuel Correia; Andre Peeters; Karl Matz; Phillippe Lyrer; Gord Gubitz; Stephen J Phillips; Antonio Arauz
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

Review 10.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321
View more
  6 in total

1.  Critical early thrombolytic and endovascular reperfusion therapy for acute ischemic stroke victims: a call for adjunct neuroprotection.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2015-08-29       Impact factor: 6.829

2.  Italian guidelines on thrombolysis indications in ischemic stroke have been revised after the IST-3 trial and Cochrane review.

Authors:  Maurizio Paciaroni
Journal:  Intern Emerg Med       Date:  2014-07-23       Impact factor: 3.397

3.  Safety and efficacy even after 90 years of age should prompt removal of upper age limits in systemic thrombolysis for stroke.

Authors:  Maurizio Balestrino; Laura Strada; Chiara Bruno; Cinzia Finocchi; Carlo Gandolfo
Journal:  Intern Emerg Med       Date:  2014-06-17       Impact factor: 3.397

4.  Thrombolysis in the elderly: yes but with caution.

Authors:  Simona Sacco; Silvia Ricci; Francesca Pistoia; Antonio Carolei
Journal:  Intern Emerg Med       Date:  2014-06-17       Impact factor: 3.397

5.  Safety and feasibility of intravenous rt-PA in the Emergency Department without a neurologist-based stroke unit: an observational study.

Authors:  Andrea Tampieri; Eugenio Giovannini; Anna Maria Rusconi; Lorenzo Cristoni; Daniela Bendanti; Patrizia Cenni; Tiziano Lenzi
Journal:  Intern Emerg Med       Date:  2014-11-28       Impact factor: 3.397

6.  Fast neuroprotection (fast-NPRX) for acute ischemic stroke victims: the time for treatment is now.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-11-07       Impact factor: 6.829
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.